Skip to main content
Premium Trial:

Request an Annual Quote

Here's Lithuania

Lithuania is looking to become a new leader in biotech, reports Bernard Dichek at Nature's Trade Secrets blog, and the country is turning to Israel's biotech sector as a model. The country recently hosted a life sciences conference that drew about 800 attendees, including an Israeli delegation, he adds.

Dicheck notes, that like the Israeli industry a few years ago, Lithuania's "two main selling points seem to be 'good science + low costs.'" Science in Lithuania harkens back to when the Soviet Union established an enzymology institute there, and a few spinoff companies have been acquired by larger companies in recent years.

Additionally, Dichek writes that Lithuania also has a large number of expatriates, some of whom already work in biotech, who could return. "However in order for that trend to continue and for Lithuania to become a center of innovation, the country will have to succeed in attracting foreign investment," Dichek says. "The lack of a local venture capital community, stock exchange and other financial institutions that provide risk-oriented capital is a drawback to this."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.